ImmunoCellular Therapeutics, Ltd.
21900 Burbank Boulevard
3rd Floor
Woodland Hills,
CA 91367
United States - Map
Phone: 818-992-2907
Fax: 818-992-2908
Web Site: http://www.imuc.com
| ImmunoCellular Therapeutics, Ltd., a development stage company, focuses on developing and commercializing therapeutics to fight cancer using the immune system. The companys product candidate portfolio includes peptide based cellular immunotherapies targeting cancer stem cells, cellular immunotherapies targeting cancer antigens, and monoclonal antibodies to diagnose and treat various cancers. Its lead product candidate is a dendritic cell based vaccine, which has completed Phase I clinical trial for the treatment of glioblastoma multiforme, a type of brain tumor. ImmunoCellular Therapeutics has a research agreement with Antitope, Ltd. for the humanization of monoclonal antibodies. The company is based in Woodland Hills, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. John S. Yu M.D., 46
Chairman, Chief Scientific Officer, Member of Compensation Committee and Member of Nominating & Corp. Governance Committee |
$
48.00K | N/A | Dr. Manish Singh Ph.D., MBA, 40
Chief Exec. Officer, Pres |
$
175.00K | N/A | Mr. Kirk Peacock , 40
Chief Financial Officer, Principal Accounting Officer and Treasurer |
$
96.00K | N/A | Mr. Sanford J. Hillsberg J.D., 61
Co-Founder and Sec. |
N/A
| N/A | Dr. James G. Bender Ph.D.M.P.H.,
VP of Clinical Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.28% Nasdaq 
Profile
